The primary objective of this pilot project is to establish a small blood volume assay that can be used inpediatric SLE patients, a critically underserved population. We will establish and validate quantitative assaysof apoptotic cell clearance and cytokine secretion in response to apoptotic cell phagocytosis using smallblood volumes, by using flow cytometry to quantify clearance, and multiplex cytokine assays to quantifysecretion of several cytokines in very small volumes of supernatant. These assays will then be applied in apilot way to a population of pediatric patients with SLE.Apoptotic cells, a potentially important antigen in SLE, are normally cleared by phagocytes in an antiinflammatory,tolerance-inducing way. Dysregulation of this process is thought to lead to systemicautoimmunity. We propose that during active disease, monocytes from SLE patients have diminished antiinflammatory(TGF- beta and IL-10) and increased pro-inflammatory (TNF-alpha, IL-1, IFN-a, IL-12) cytokinesecretion in response to apoptotic cells, which contributes to SLE propagation, disease flares, and tissuedamage. The relevance of such pathways in pediatric SLE is unknown. We have shown that adult SLEpatients have strikingly decreased anti-inflammatory cytokine secretion in response to apoptotic cellscompared to normal controls. However, this defect in TGF-beta secretion did not reflect a defect in uptake,indicating that the SLE monocytes are capable of phagocytosing the apoptotic cells.The relatively large blood volumes required for these assays present a significant challenge to directlyaddressing these pathways in children. However, with the small blood volume assays and multiplex ELISAproposed in this pilot project, 16 cytokines can be assayed from a single 250 mu l supernatant sample (an 8-fold reduction in supernatant volume). Thus, we should be able to generate the necessary supernatantvolume with only 2 cc of blood, making this assay accessible to the pediatric SLE population.These techniques may have broad applicability for Dr. Sule, as she begins to grow her career in pediatricrheumatology. They may also enable studies in the pediatric population with rheumatic diseases which are currently not pursued due to logistic issues and difficulties with scaling down sample volumes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
1P30AR053503-01
Application #
7133592
Study Section
Special Emphasis Panel (ZAR1-EHB-D (O1))
Project Start
2006-03-01
Project End
2011-02-28
Budget Start
2006-03-01
Budget End
2007-07-31
Support Year
1
Fiscal Year
2006
Total Cost
$28,316
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
McGrath-Morrow, Sharon A; Ndeh, Roland; Helmin, Kathryn A et al. (2018) DNA methylation regulates the neonatal CD4+ T-cell response to pneumonia in mice. J Biol Chem 293:11772-11783
Shi, Jing; Darrah, Erika; Sims, Gary P et al. (2018) Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis. Ann Rheum Dis 77:141-148
Lee, Yvonne C; Bingham 3rd, Clifton O; Edwards, Robert R et al. (2018) Association Between Pain Sensitization and Disease Activity in Patients With Rheumatoid Arthritis: A Cross-Sectional Study. Arthritis Care Res (Hoboken) 70:197-204
Wohlfahrt, Alyssa; Bingham 3rd, Clifton O; Marder, Wendy et al. (2018) Responsiveness of Patient Reported Outcomes Measurement Information System (PROMIS) Measures in RA Patients Starting or Switching a DMARD. Arthritis Care Res (Hoboken) :
Leung, Ying Ying; Ogdie, Alexis; Orbai, Ana-Maria et al. (2018) Classification and Outcome Measures for Psoriatic Arthritis. Front Med (Lausanne) 5:246
Cohen, Ezra M; Edwards, Robert R; Bingham 3rd, Clifton O et al. (2018) Pain and Catastrophizing in Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study. J Clin Rheumatol :
Bartlett, S J; Gutierrez, A K; Butanis, A et al. (2018) Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis. Qual Life Res 27:2443-2451
Darrah, Erika; Yu, Fang; Cappelli, Laura C et al. (2018) Association of baseline peptidylarginine deiminase 4 autoantibodies with favorable response to treatment escalation in rheumatoid arthritis. Arthritis Rheumatol :
Cappelli, Laura C; Konig, Maximilian F; Gelber, Allan C et al. (2018) Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis. Arthritis Res Ther 20:59
Igusa, Takeru; Hummers, Laura K; Visvanathan, Kala et al. (2018) Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer. Ann Rheum Dis 77:1179-1186

Showing the most recent 10 out of 125 publications